NanoRepro AG (ETR:NN6)
1.490
+0.005 (0.34%)
May 14, 2026, 5:35 PM CET
NanoRepro AG Market Cap
NanoRepro AG has a market cap or net worth of €18.73 million as of May 14, 2026. Its market cap has increased by 5.32% in one year.
Market Cap
18.73M
Enterprise Value
11.44M
Revenue
5.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.49
Market Cap Chart
Since October 10, 2008, NanoRepro AG's market cap has increased from 12.43M to 18.73M, an increase of 50.73%. That is a compound annual growth rate of 2.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 18.73M | -1.33% |
| Dec 30, 2025 | 18.98M | 7.89% |
| Dec 30, 2024 | 17.60M | -31.51% |
| Dec 29, 2023 | 25.69M | -9.71% |
| Dec 30, 2022 | 28.45M | -70.56% |
| Dec 30, 2021 | 96.65M | 175.48% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 49.13B |
| Siemens Healthineers AG | 37.82B |
| Bayer Aktiengesellschaft | 37.76B |
| Fresenius SE & Co. KGaA | 22.26B |
| FamiCord AG | 71.30M |
| Pentixapharm Holding AG | 53.28M |
| MeVis Medical Solutions AG | 42.95M |
| aap Implantate AG | 29.21M |